Proteovant Therapeutics
New York, New York, United States
About Proteovant Therapeutics
Proteovant Therapeutics is a biotechnology company that utilizes protein degradation research in the development of medicines for diseases.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Funding stage: M&A
- Last round: Seed (Jan 2023)
- Website: proteovant.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Genetics, Life Science, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/proteovant-therapeutics-2601271 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.